
### [MONDO:0018150](http://purl.obolibrary.org/obo/MONDO_0018150)
**Label:** Gaucher disease

**Subclasses:** [MONDO:0009265](http://purl.obolibrary.org/obo/MONDO_0009265) (Gaucher's disease type I), [MONDO:0009266](http://purl.obolibrary.org/obo/MONDO_0009266) (Gaucher's disease type II), [MONDO:0009267](http://purl.obolibrary.org/obo/MONDO_0009267) (Gaucher's disease type III), [MONDO:0009268](http://purl.obolibrary.org/obo/MONDO_0009268) (Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome), [MONDO:0011945](http://purl.obolibrary.org/obo/MONDO_0011945) (Gaucher's disease perinatal lethal), [MONDO:0012517](http://purl.obolibrary.org/obo/MONDO_0012517) (atypical Gaucher's disease due to saposin c deficiency), 

**Mapped go classes:** [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0006680](http://purl.obolibrary.org/obo/GO_0006680) (glucosylceramide catabolic process), [GO:1903206](http://purl.obolibrary.org/obo/GO_1903206) (negative regulation of hydrogen peroxide-induced cell death), [GO:1904457](http://purl.obolibrary.org/obo/GO_1904457) (positive regulation of neuronal action potential), [GO:0043589](http://purl.obolibrary.org/obo/GO_0043589) (skin morphogenesis), [GO:0051246](http://purl.obolibrary.org/obo/GO_0051246) (regulation of protein metabolic process), [GO:0051247](http://purl.obolibrary.org/obo/GO_0051247) (positive regulation of protein metabolic process), [GO:0023021](http://purl.obolibrary.org/obo/GO_0023021) (termination of signal transduction), [GO:0001664](http://purl.obolibrary.org/obo/GO_0001664) (G-protein coupled receptor binding), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0033574](http://purl.obolibrary.org/obo/GO_0033574) (response to testosterone), [GO:1903052](http://purl.obolibrary.org/obo/GO_1903052) (positive regulation of proteolysis involved in cellular protein catabolic process), [GO:1905037](http://purl.obolibrary.org/obo/GO_1905037) (autophagosome organization), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0032715](http://purl.obolibrary.org/obo/GO_0032715) (negative regulation of interleukin-6 production), [GO:0004348](http://purl.obolibrary.org/obo/GO_0004348) (glucosylceramidase activity), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0007193](http://purl.obolibrary.org/obo/GO_0007193) (adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway), [GO:0043408](http://purl.obolibrary.org/obo/GO_0043408) (regulation of MAPK cascade), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0033561](http://purl.obolibrary.org/obo/GO_0033561) (regulation of water loss via skin), [GO:0046512](http://purl.obolibrary.org/obo/GO_0046512) (sphingosine biosynthetic process), [GO:0043243](http://purl.obolibrary.org/obo/GO_0043243) (positive regulation of protein complex disassembly), [GO:0046513](http://purl.obolibrary.org/obo/GO_0046513) (ceramide biosynthetic process), [GO:0043202](http://purl.obolibrary.org/obo/GO_0043202) (lysosomal lumen), [GO:0008047](http://purl.obolibrary.org/obo/GO_0008047) (enzyme activator activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:0006665](http://purl.obolibrary.org/obo/GO_0006665) (sphingolipid metabolic process), [GO:0004565](http://purl.obolibrary.org/obo/GO_0004565) (beta-galactosidase activity), [GO:0097066](http://purl.obolibrary.org/obo/GO_0097066) (response to thyroid hormone), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0071310](http://purl.obolibrary.org/obo/GO_0071310) (cellular response to organic substance), [GO:0032268](http://purl.obolibrary.org/obo/GO_0032268) (regulation of cellular protein metabolic process), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:1903061](http://purl.obolibrary.org/obo/GO_1903061) (positive regulation of protein lipidation), [GO:0032269](http://purl.obolibrary.org/obo/GO_0032269) (negative regulation of cellular protein metabolic process), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:1905574](http://purl.obolibrary.org/obo/GO_1905574) (ganglioside GM2 binding), [GO:1905573](http://purl.obolibrary.org/obo/GO_1905573) (ganglioside GM1 binding), [GO:1905572](http://purl.obolibrary.org/obo/GO_1905572) (ganglioside GM1 transport to membrane), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0036268](http://purl.obolibrary.org/obo/GO_0036268) (swimming), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:1905577](http://purl.obolibrary.org/obo/GO_1905577) (ganglioside GP1c binding), [GO:1905576](http://purl.obolibrary.org/obo/GO_1905576) (ganglioside GT1b binding), [GO:1905575](http://purl.obolibrary.org/obo/GO_1905575) (ganglioside GM3 binding), [GO:0009268](http://purl.obolibrary.org/obo/GO_0009268) (response to pH), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:1904925](http://purl.obolibrary.org/obo/GO_1904925) (positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0070050](http://purl.obolibrary.org/obo/GO_0070050) (neuron cellular homeostasis), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:1901805](http://purl.obolibrary.org/obo/GO_1901805) (beta-glucoside catabolic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0019216](http://purl.obolibrary.org/obo/GO_0019216) (regulation of lipid metabolic process), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0071548](http://purl.obolibrary.org/obo/GO_0071548) (response to dexamethasone), 

**Class expressions from DL-Learner:**

- [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 63.89%
- [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 63.89%
- [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) 63.89%
- [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) 63.89%
- [GO:0035594](http://purl.obolibrary.org/obo/GO_0035594) (ganglioside binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0035594](http://purl.obolibrary.org/obo/GO_0035594) (ganglioside binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0046625](http://purl.obolibrary.org/obo/GO_0046625) (sphingolipid binding) and [GO:0051861](http://purl.obolibrary.org/obo/GO_0051861) (glycolipid binding) 63.89%
- [GO:0031406](http://purl.obolibrary.org/obo/GO_0031406) (carboxylic acid binding) and [GO:0043208](http://purl.obolibrary.org/obo/GO_0043208) (glycosphingolipid binding) and [GO:0097001](http://purl.obolibrary.org/obo/GO_0097001) (ceramide binding) 63.89%


